ARIScience

our mission is to reduce societal burden of human disease. we do it through discovering small molecule therapeutics that can interrupt causative proteins in disease pathways. we target aberrant, over-expressed and pathogenic proteins that lie in neurodegenerative diseases, infectious (viral/bacterial/fungal) diseases and inflammatory conditions.